Endovas 40 – Endocrine Pharma

Refused App ID 6115206 Class 5 Word

Trademark information

IP India · live record
Application ID
6115206
Status
Refused
Sub status
Not Applicable
Date of application
18 September 2023
Classes
5
Type
Word
Proprietor
Endocrine Pharma Private No. 03, Survey No 43 D/1, Shreya Nagar, Behind 1 St Gate, Vitthal Engineering Works, Gokul Road, Hubballi Dharwad Ka 580030 In
Attorney
Newton Reginald[25853]No 6, Dhanammal Street Spurtank Road Chetpet Chennai 600031
State
Karnataka
Filing mode
e-Filing
IP office
Chennai
Used since
—
Valid / upto
—

Goods & services

Class 5

Class 5Pharmaceuticals; Antibacterial pharmaceuticals;Homeopathic pharmaceuticals; Capsules, empty, forpharmaceuticals; Pharmaceuticals, medical and veterinarypreparations; Capsules sold empty for pharmaceuticals;Pharmaceuticals for treating respiratory diseases;Pharmaceuticals for the treatment of cancer;Pharmaceuticals for the treatment of infectious diseases;Pharmaceuticals for the treatment of erectile dysfunction;Pharmaceuticals for the treatment of viral diseases;Pharmaceuticals for the treatment of bone diseases; Skinpatches for the transdermal delivery of pharmaceuticals;Injectable pharmaceuticals for treatment of anaphylacticreactions; Capsules made of dendrimer-based polymers, forpharmaceuticals; Pharmaceuticals for the prevention andtreatment of cancer; Pharmaceuticals for treating thesymptoms of radiation sickness; Drug delivery agents in theform of edible wafers for wrapping powderedpharmaceuticals; Drug delivery agents consisting ofcompounds that facilitate delivery of a wide range ofpharmaceuticals; Drug delivery agents in the form ofpowders that provide controlled release of the activeingredients for a wide variety of pharmaceuticals; Drugdelivery agents in the form of capsules that providecontrolled release of

Uploaded documents

Sign in to open
1 TM-A(TRADE MARKS APPLICATION) 18 Sep 2023
2 Reply to Exam Report (MIS-R) 12 Dec 2023
3 Documents in support of Show cause Hearing (SCH) 30 Jun 2025
4 Authorization Letter 09 Jul 2025

Correspondence and notices

1 EXAMINATION REPORT 16555807 16 Nov 2023
2 Hearing Notice (Show Cause) 19962148 26 Mar 2025
3 Adjourned Notice 20223480 15 May 2025
4 Hearing Notice for Application No. 6115206 20285956 26 May 2025
5 Tribunal Refused Notice for : 6115206 20544153 · 7329764 10 Jul 2025

Frequently asked questions

Endovas 40 was applied for on 18 September 2023.

The application was filed by Endocrine Pharma.

Class 5.

As per IP India, the status is Refused.

The listed application ID of Endovas 40 is 6115206.

Trademark attorney Newton Reginald.